Compare DSWL & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | CPIX |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 59.5M |
| IPO Year | 1995 | 2009 |
| Metric | DSWL | CPIX |
|---|---|---|
| Price | $3.35 | $3.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.4K | ★ 218.7K |
| Earning Date | 11-13-2025 | 03-03-2026 |
| Dividend Yield | ★ 6.08% | N/A |
| EPS Growth | ★ 20.23 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $65,664,000.00 | $41,278,349.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.22 | ★ N/A |
| Revenue Growth | N/A | ★ 12.21 |
| 52 Week Low | $1.93 | $1.85 |
| 52 Week High | $4.48 | $7.25 |
| Indicator | DSWL | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 43.74 |
| Support Level | $3.00 | $3.66 |
| Resistance Level | $3.43 | $4.92 |
| Average True Range (ATR) | 0.14 | 0.40 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 72.92 | 9.09 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.